XTL Biopharmaceuticals Ltd (XTLB)
2.693
+0.04
(+1.62%)
USD |
NASDAQ |
May 17, 16:00
2.71
+0.02
(+0.63%)
Pre-Market: 20:00
XTL Biopharmaceuticals Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2014 | 0.516M |
| September 30, 2014 | 0.166M |
| June 30, 2014 | 0.538M |
| March 31, 2014 | 0.279M |
| December 31, 2013 | -0.945M |
| September 30, 2013 | 3.782M |
| June 30, 2013 | -0.003M |
| March 31, 2013 | 0.502M |
| December 31, 2012 | -0.729M |
| September 30, 2012 | 0.16M |
| June 30, 2012 | -1.621M |
| March 31, 2012 | 0.981M |
| Date | Value |
|---|---|
| December 31, 2011 | -0.983M |
| September 30, 2011 | 0.15M |
| June 30, 2011 | 1.313M |
| March 31, 2011 | -1.852M |
| September 30, 2010 | -0.024M |
| June 30, 2010 | -0.005M |
| March 31, 2010 | -0.026M |
| December 31, 2009 | 0.00 |
| September 30, 2009 | -0.024M |
| June 30, 2009 | 0.00 |
| March 31, 2009 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Compugen Ltd | -- |
| Pluri Inc | 5.668M |
| BioLine Rx Ltd | -20.40M |
| Can Fite Biofarma Ltd | -- |
| BiomX Inc | -0.006M |
Cash from Investing (Quarterly) Related Metrics
| Free Cash Flow Yield | -16.90% |